In summary, our data demonstrated that circulating MIR4435-2HG and lnc-POLD3-2 either alone or in combination could be used as sensitive biomarkers of HCC detection in patients with chronic HBV infection. The gene discussed is POLD3; the disease is hepatocellular carcinoma.